SCOPUS 정보 검색 플랫폼

Volumn 8, Issue 2, 2007, Pages 315-316

Intramolecular antigenicity of MUC1, a candidate for cancer vaccines

Author keywords

Antigenicity; MUC1; Vaccine development

Indexed keywords

CA 15-3 ANTIGEN; CANCER VACCINE; MUC1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; GENETICS; HUMAN; IMMUNOLOGY; NEOPLASM;

CA-15-3 ANTIGEN; CANCER VACCINES; HUMANS; NEOPLASMS;

EID: 40449142621 PISSN: 15137368 EISSN: 2476762X Source Type: Journal
DOI: None Document Type: Article

Times cited : (2)

References (12)

1
- 24744434192
- MUC1 as a target antigen for cancer immunotherapy
- Acres B, Limacher JM (2005). MUC1 as a target antigen for cancer immunotherapy. Expert Rev Vaccines, 4, 493-502.
- (2005) Expert Rev Vaccines , vol.4 , pp. 493-502
- Acres, B.¹ Limacher, J.M.²

2
- 0032910544
- MUC1 and breast cancer
- Apostolopoulos V, Pietersz GA, McKenzie IF (1999). MUC1 and breast cancer. Curr Opin Mol Ther, 1, 98-103.
- (1999) Curr Opin Mol Ther , vol.1 , pp. 98-103
- Apostolopoulos, V.¹ Pietersz, G.A.² McKenzie, I.F.³

3
- 0034443614
- MUC1 in carcinoma-host interactions
- Denda-Nagai K, Irimura T (2000). MUC1 in carcinoma-host interactions. Glycoconj J, 17, 649-58.
- (2000) Glycoconj J , vol.17 , pp. 649-658
- Denda-Nagai, K.¹ Irimura, T.²

4
- 33947095629
- Human tumor antigens, immunosurveillance, and cancer vaccines
- Finn OJ (2006). Human tumor antigens, immunosurveillance, and cancer vaccines. Immunol Res, 36, 73-82.
- (2006) Immunol Res , vol.36 , pp. 73-82
- Finn, O.J.¹

5
- 33747275828
- Immunology of O-glycosylated proteins: approaches to the design of a MUC1 glycopeptidebased tumor vaccine
- Hanisch FG, Ninkovic T (2006). Immunology of O-glycosylated proteins: approaches to the design of a MUC1 glycopeptidebased tumor vaccine. Curr Protein PeptSci, 7, 307-15.
- (2006) Curr Protein PeptSci , vol.7 , pp. 307-315
- Hanisch, F.G.¹ Ninkovic, T.²

6
- 0003395743
- Prediction of protein antigenic determinants from amino acid sequences
- Hopp TP, Woods KR (1981). Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA, 86,152-6.
- (1981) Proc Natl Acad Sci USA , vol.86 , pp. 152-156
- Hopp, T.P.¹ Woods, K.R.²

7
- 33947303040
- Synthetic glycopeptides for the development of cancer vaccines
- Liakatos, Kunz H (2007). Synthetic glycopeptides for the development of cancer vaccines. Curr Opin Mol Ther, 9, 35-44.
- (2007) Curr Opin Mol Ther , vol.9 , pp. 35-44
- Liakatos, K.H.¹

8
- 33947523438
- MUC1 a therapeutic target in oncology
- Limacher JM, Acres B (2007). MUC1 a therapeutic target in oncology. Bull Cancer, 94,253-7.
- (2007) Bull Cancer , vol.94 , pp. 253-257
- Limacher, J.M.¹ Acres, B.²

9
- 0033013931
- Therapeutic aspects of polymorphic epithelial mucin in adenocarcinoma
- Miles DW, Taylor-Papadimitriou J (1999). Therapeutic aspects of polymorphic epithelial mucin in adenocarcinoma. Pharmacol Ther, 82, 97-106.
- (1999) Pharmacol Ther , vol.82 , pp. 97-106
- Miles, D.W.¹ Taylor-Papadimitriou, J.²

10
- 0030850646
- JaMBW 1.1: Java-based Molecular Biologists' Workbench
- Toldo LI (1997). JaMBW 1.1: Java-based Molecular Biologists' Workbench. Comput Appl Biosci, 13, 475-6.
- (1997) Comput Appl Biosci , vol.13 , pp. 475-476
- Toldo, L.I.¹

11
- 33947163463
- MUC1 in endometriosis and ovarian cancer
- Vlad AM, Diaconu I, Gantt KR (2006). MUC1 in endometriosis and ovarian cancer. Immunol Res, 36,229-36.
- (2006) Immunol Res , vol.36 , pp. 229-236
- Vlad, A.M.¹ Diaconu, I.² Gantt, K.R.³

12
- 1142286444
- MUC1 immunobiology: from discovery to clinical applications
- Vlad AM, Kettel JC, Alajez NM, et al (2004). MUC1 immunobiology: from discovery to clinical applications. Adv Immunol, 82, 249-93.
- (2004) Adv Immunol , vol.82 , pp. 249-293
- Vlad, A.M.¹ Kettel, J.C.² Alajez, N.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.